Status:
UNKNOWN
Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
Lead Sponsor:
Korea University
Conditions:
Atrial Fibrillation
Thromboembolism
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to investigate the appropriate duration of dabigatran use after radiofrequency catheter ablation for paroxysmal atrial fibrillation in patients with low thromboembolic ris...
Eligibility Criteria
Inclusion
- paroxysmal AF undergoing catheter ablation
- CHA2DS2-VASc score \<= 1
- informed consent
Exclusion
- persistent AF
- CHA2DS2-VASc score \> 2
- prior CVA
- prior atnicoagulant
- severe HF
- abnormal liver or renal function
- history of severe bleeding
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2017
Estimated Enrollment :
464 Patients enrolled
Trial Details
Trial ID
NCT02313584
Start Date
December 1 2014
End Date
September 1 2017
Last Update
December 10 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.